A recent episode of the reality TV show *The Kardashians* revealed that Kim Kardashian has “holes” in her brain, according to a brain scan shown on the program. The scan reportedly displayed low activity in several regions, and celebrity psychologist Dr. Daniel Amen identified what he described as holes in her frontal lobe. The condition is thought to be potentially caused by chronic stress.
Kardashian, who is currently studying for the California Bar exam, recently reported excessive sleepiness and was diagnosed with a small brain aneurysm. The scan results have sparked speculation among fans and observers. Some theorize that she may be considering implantable brain‑computer interfaces (BCIs) or other experimental treatments. Neuralink, the company co‑founded by Elon Musk, has been developing implantable BCIs aimed at ushering in a new era of superintelligence. Musk announced in 2024 that a chip had been successfully implanted in a human subject, and the company is moving toward human trials. Other firms, such as Synchron and Blackrock Neurotech, are also testing similar technology.
Other commentators have suggested that Kardashian’s reduced brain activity could be an unacknowledged side effect of long COVID, and that she might be exploring experimental options rather than evidence‑based therapies. The incident has ignited discussion about the potential medical adoption of implantable computer chips, with some arguing that they could offer viable solutions for certain conditions. The development carries significant implications for the possibility of restoring or enhancing cognitive function through BCIs.
As research in this field continues to evolve, further debate about the benefits and risks of implantable BCIs is inevitable. For now, it remains unclear how Kardashian will address her brain health and what her case may mean for the broader conversation about the medical applications of implantable brain‑computer interfaces.
Comments are closed for this story.